Evidence map›Paper›PMID 32637652›Full record

ArticleEuropean stroke journal2020

Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group.

Dominique A Cadilhac, Joosup Kim, Alastair Wilson, Eivind Berge, Anita Patel, Myzoon Ali, Jeffrey Saver, Hanne Christensen, Matthieu Cuche, Sean Crews and 16 more

Abstract read
In one paragraph

Article in European stroke journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Article
  3. A lifetime economic model of mortality and secondary care use for patients discharged from hospital following acute stroke.International journal of stroke : official journal of the International Stroke Society · 2025
    Article
  4. Costs of Neurological Disorders.Neuroepidemiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Dominique A CadilhacStroke and Ageing Research, School of Clinical Sciences at Monash Health, Monash University.ORCID https://orcid.org/0000-0001-8162-682X
Joosup KimStroke and Ageing Research, School of Clinical Sciences at Monash Health, Monash University.ORCID https://orcid.org/0000-0002-4079-0428
Alastair WilsonInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Eivind BergeDepartment of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Anita PatelAnita Patel Health Economics Consulting Ltd, London, UK.
Myzoon AliInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Jeffrey SaverComprehensive Stroke Center and Department of Neurology, University of California, Los Angeles, CA, USA.
Hanne ChristensenBispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
Matthieu CucheMedtronic International Trading Sàrl, Tolochenaz, Switzerland.
Sean CrewsPenumbra, Inc., One Penumbra Place, Alameda, CA, USA.
Olivia WuHealth Economics and Health Technology Assessment Research Group, University of Glasgow, Glasgow, UK.
Marine ProvoyeurPenumbra GmbH, Berlin, Germany.
Peter McMeekinFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.ORCID https://orcid.org/0000-0003-0946-7224
Isabelle Durand-ZaleskiHealth Economics, Assistance Publique Hôpitaux de Paris, Paris, France.ORCID https://orcid.org/0000-0002-4078-1476
Gary A FordUniversity of Oxford, UK.
Natalia MuhlemannNestle Health Science, Nestec S.A., Vevey, Switzerland.
Philip M BathStroke Trials Unit, University of Nottingham, Nottingham, UK.
Azmil H Abdul-RahimInstitute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.ORCID https://orcid.org/0000-0002-1318-4027
Katharina SunnerhagenSection of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Atte MeretojaDepartment of Medicine, University of Melbourne, Victoria, Australia.
Vincent ThijsStroke Division, the Florey Institute of Neuroscience and Mental Health.
Christian WeimarDepartment of Neurology, University Hospital Essen, Essen, Germany.
Ayrton MassaroDepartment of Neurology, Hospital Sirio-Libanes, São Paulo, Brazil.
Annemarei RantaDepartment of Medicine, University of Otago, Wellington, New Zealand.
Kennedy R LeesSchool of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK.
ESO Health Economics Working group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionApproaches to economic evaluations of stroke therapies are varied and inconsistently described. An objective of the European Stroke Organisation (ESO) Health Economics Working Group is to standardise and improve the economic evaluations of interventions for stroke.

methodsThe ESO Health Economics Working Group and additional experts were contacted to develop a protocol and a guidance document for data collection for economic evaluations of stroke therapies. A modified Delphi approach, including a survey and consensus processes, was used to agree on content. We also asked the participants about resources that could be shared to improve economic evaluations of interventions for stroke.

resultsOf 28 experts invited, 16 (57%) completed the initial survey, with representation from universities, government, and industry. More than half of the survey respondents endorsed 13 specific items to include in a standard resource use questionnaire. Preferred functional/quality of life outcome measures to use for economic evaluations were the modified Rankin Scale (14 respondents, 88%) and the EQ-5D instrument (11 respondents, 69%). Of the 12 respondents who had access to data used in economic evaluations, 10 (83%) indicated a willingness to share data. A protocol template and a guidance document for data collection were developed and are presented in this article.

conclusionThe protocol template and guidance document for data collection will support a more standardised and transparent approach for economic evaluations of stroke care.

Indexed as

economic evaluationEuroQolhealth outcomeshealth policymodified Rankin ScaleStroke

Identifiers

PMID32637652
PMCPMC7313366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.